Evidence map›Paper›PMID 24396828›Full record

Trial reportBioMed research international2013

Expression analysis of SPARC/osteonectin in oral squamous cell carcinoma patients: from saliva to surgical specimen.

Gabriella Aquino, Rocco Sabatino, Monica Cantile, Corrado Aversa, Franco Ionna, Gerardo Botti, Elvira La Mantia, Francesca Collina, Gabriella Malzone, Giuseppe Pannone and 3 more

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Insight into the preformed albumin corona onAsian journal of pharmaceutical sciences · 2019
    Article
  5. Article
  6. Article
  7. Knock-down of ABCE1 gene induces G1/S arrest in human oral cancer cells.International journal of clinical and experimental pathology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Gabriella AquinoPathology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Rocco SabatinoPathology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Monica CantilePathology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Corrado AversaHead and Neck Medical Oncology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Franco IonnaHead and Neck Medical Oncology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Gerardo BottiPathology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Elvira La MantiaPathology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Francesca CollinaPathology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Gabriella MalzonePathology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Giuseppe PannoneDepartment of Surgical Sciences, Section of Anatomic Pathology, Second Section of Oral Pathology, University of Foggia, Foggia, Italy.
Nunzia Simona LositoPathology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Renato FrancoPathology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Francesco LongoHead and Neck Medical Oncology Unit, Istituto Nazionale Tumori "Fondazione Pascale"-IRCCS, Napoli, Italy.
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" · ITUniversity of Foggia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral squamous cell carcinoma (OSCC) remains a significant cause of morbidity and mortality, with approximately 540,000 new cases annually worldwide. The molecular mechanisms related to the pathogenesis of this disease are still poorly understood. The discovery of a molecular marker that allows the early detection of this cancer, which can be easily identified in biological samples, such as saliva, without intervening in advanced stages, is a challenge. Numerous studies have identified a panel of molecular markers differently expressed in OSCC and normal oral mucosa. In particular, it was found an aberrant expression of matricellular glycoprotein SPARC. SPARC is involved in normal tissue remodeling, regulating the deposition of extracellular matrix, but also in neoplastic transformation. In fact, aberrant SPARC expression was detected both in stromal cells associated with cancer and in tumor cells. The aim of our study was the evaluation of SPARC on a retrospective series of 119 OSCC cases and the validation of the obtained data on a prospective series of 27 patients with OSCC, of whom we have previously collected saliva, and smeared material. The obtained results were correlated with each other and with clinical pathological parameters at our disposal. The study demonstrated a prognostic value of SPARC, especially with regard to its expression in the stroma surrounding OSCC (P < 0.05).

Indexed as

Carcinoma, Squamous CellGene Expression Regulation, NeoplasticMouth NeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm ProteinsOsteonectinRetrospective StudiesSalivaSalivary Proteins and PeptidesNeoplasm ProteinsOsteonectinSalivary Proteins and PeptidesSPARC protein, human

Identifiers

PMID24396828
PMCPMC3876772
OpenAlexW2074007260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.